- Genesis obtained the registration certification of RSV /ADV Antigen Rapid test kits
- Geneis participate in AACC meeting at Chicago
- Genesis participate in the 63rd China International Medical Equipment Fair(CMEF 2010 Spring)
- Genesis participate American Association of Clinical Chemistry's (AACC)
- Exhibition Information 2013
- Geneis participate in Düsseldorf Messe MEDICA – International Trade Fair & Congress for Medicine
- GENESIS Launched Mycoplasma Pneumoniae
Antigen Rapid Diagnostic Test Kit
- Genesis’ Sales & Marketing Center was launched
- Paper: Rapid diagnosis of Mycoplasma pneumoniae in children with pneumonia by an immuno-chromatographic antigen assay
- Overview of Influenza Surveillance in China
- Collection of Technical Documents for Chinese National Influenza Center
- Infectivity, Transmission, and Pathology of Human-Isolated H7N9 Influenza Virus in Ferrets and Pigs
- China's new WHO flu monitoring center seeks to reverse criticism
- No child should die of TB.
- Tuberculosis is a global pandemic
- XDR-TB has been confirmed in more than 100 countries around the world
- Efforts to contain the spread of the tenacious form of TB have proven insufficient, and HIV clinics and hospitals have become the most likely source of infectio
GENESIS completes the innovation technology upgrading project. The second phase expansion project plan is started.
SFDA: Mycoplasma Pneumoniae Antigen Raipd Test Device Kit (Colloidal Gold) Medical Device Registration Certificate, No. S20163400806.
Genesis' R& D Center was launched in the Economic and Technological Development Zone, is mainly responsible for Genesis health products of IVD.
Genesis' Marketing Center is responsible for Kaibili brand in the domestic market sales, to promote"product + service" business model and improve the market.
Genesis' Postdoctoral Station was approved by the Hangzhou economic and Technological Development Zone.
After assessment, publicity, approval process, GENESIS was awarded "National High-Tech Pharmaceutical Enterprises" certificate.
Production range changed into Categories Two 6840 clinical detection and analysis instruments; Categories Three in vitro diagnostic reagents * * *.
SFDA: Adenovirus Antigen Raipd Test Device Kit (Colloidal Gold) Medical Device Registration Certificate,No.3401509.
Shangyu Changda plastic products Co., Ltd. upgraded to the Shaoxing Chuangda Medical Devices Co., Ltd.
SFDA: RSV Antigen Raipd Test Device Kit (Colloidal Gold) Medical Device Registration Certificate, No. S3400267.
Anniversary Ten-Year Celebrations. Colorful programs: Arts Festival; Long service award; Best Newcomer Award; Best Teamwork Award; Advanced employees Awards as
The company's major shareholders changed. Now, GENESIS is a joint-venture of US and Chinese Companies of Diagnostic products.
SFDA: Flu A+B Virus Antigen Raipd Test Device Kit (Colloidal Gold) Medical Device Registration Certificate,No.3401262.
May 8, 2009, China famous immune biochemistry expert, academician of the Chinese Academy of Engineering, Shen Bei Fen academician of Academy of Military Medical
The production range was changed into second, three class 6840 in vitro diagnostic reagents.
Shangyu Chang Da plastic products Co., Ltd. was established, and has become the strategic partner of GENESIS.
SFDA: Mycobacterium Tuberculosis Rapid Test Device Kit (Colloidal Gold) Medical Device Registration Certificate, No. SS20050073.
SFDA: Flu A Virus Antigen Raipd Test Device Kit (Colloidal Gold) Medical Device Registration Certificate,No.S20050019.
Approved by the food and Drug Administration of Zhejiang Province, the company obtained a license for medical device manufacturers (second kinds of IVD ).
GENESIS was established in 2002 and registered in the Hangzhou Economic & Technology Development Zone .